Evonik Industries/€EVK

05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX

About Evonik Industries

Evonik Industries AG, a German multinational, specializes in producing specialty chemicals, primarily focusing on consumer goods, animal nutrition, and pharmaceuticals. Founded in 1873, the company operates globally and is structured into multiple segments including Specialty Additives, Nutrition & Care, and Smart Materials among others. As a publicly traded entity, it is listed on the Frankfurt Stock Exchange under the ticker EVK.

Ticker

€EVK
Sector

Primary listing

XETRA

Employees

31,273
Headquarters
Website

EVK Metrics

BasicAdvanced
€7.5B
17.47
€0.92
0.94
€1.17
7.30%

What the Analysts think about EVK

Analyst ratings (Buy, Hold, Sell) for Evonik Industries stock.

Bulls say / Bears say

Evonik reported better-than-expected first-quarter 2025 results, with adjusted EBITDA rising 7% to €560 million versus consensus of €543 million, driven by high-margin growth sectors and tight cost management. (Reuters)
Evonik projects its 2025 adjusted EBITDA to be broadly stable at €2.0–2.3 billion, supported by strict cost discipline and strong volume development in specialty additives. (Reuters)
Investor confidence is reflected in a nearly 20% year-to-date share price increase, signaling market approval of its strategic execution. (Reuters)
Second-quarter core profit fell 12% year-on-year to €509 million, and sales dropped 11% to €3.5 billion, undershooting analyst estimates amid weak demand and currency headwinds. (Reuters)
Evonik now expects full-year adjusted EBITDA at the lower end of its €2.0–2.3 billion guidance range, indicating limited upside amid ongoing market uncertainties. (Reuters)
The divestiture of its superabsorbents unit, which generated €892 million in 2023, has narrowed its revenue base and intensified exposure to current demand weaknesses. (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 8 Sept 2025.

EVK Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

EVK Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy €EVK

Sign up or log in to buy
Capital at risk
Extended hours trading

Upcoming events

No upcoming events
FAQs